ERN Joint Webinar – Rare Anterior Segment Manifestations of Hematological Disorders

Pr Nathalie Meuleman
Professor Nathalie Meuleman completed her training in Internal Medicine and Hematology at the Université libre de Bruxelles (ULB), Belgium. She conducted her doctoral research on mesenchymal stem cells at the Hematology Laboratory of the Jules Bordet Institute and obtained a PhD in Biomedical Sciences in 2010. She continues to be actively involved in translational research through the Clinical Cell Therapy Laboratory of ULB, with a particular focus on multiple myeloma and plasma cell disorders.

Since 2014, Professor Meuleman has been a Professor at the Faculty of Medicine of the Université libre de Bruxelles. She currently serves as Head of the Department of Hematology at the Jules Bordet Institute – H.U.B. (Brussels University Hospital), where she leads the clinical program in plasma cell disorders, amyloidosis, stem cell transplantation, and cellular therapies.

Professor Meuleman has served as President of the Belgian Hematology Society (2016–2019) and is a member of the Board of Directors of the Intergroupe Francophone du Myélome (IFM). She is an active member of several national and international scientific societies and has been involved in numerous academic clinical trials and translational research projects.

Her main clinical and research interests focus on multiple myeloma, AL and innovative immunotherapies, with a strong commitment to improving patient outcomes through clinical research and multidisciplinary care.

Pr Petra Lišková

Prof. Petra Lišková, MD, PhD, is a clinician-scientist and Head of the Centre for Clinical Ocular Genetics at the Department of Ophthalmology, General University Hospital in Prague and the First Faculty of Medicine, Charles University. For more than two decades, her research has focused on rare inherited and acquired corneal disorders, with particular emphasis on their genetic basis and clinical management. Since 2016, she has been leading a dedicated research laboratory alongside her clinical practice, fostering translational research that bridges molecular genetics and patient care. She is actively involved in the education and training of medical doctors, MSc students, and PhD candidates through clinical mentorship, research supervision, and academic teaching. To date, Prof. Lišková has authored 138 peer-reviewed publications and has established an internationally recognised research programme in ocular genetics.

Prof. Dr. med. Tina Dietrich-Ntoukas, FEBO

Medical studies at Georg-August-University Göttingen 1995 – 2001 with stays abroad in Paris/France, Edinburgh/Great Britain, Luzern/Switzerland und Toronto/Canada. 2001 doctorate in Histology, Institute of Anatomy, Georg-August-University Göttingen. 2002 – 2006 residency in ophthalmology at Friedrich-Alexander-University Erlangen-Nürnberg (Prof. Dr. Dr. hc mult. G.O.H. Naumann, Prof. Dr. F.E. Kruse). From 2007 to 2014 specialist, ophthalmic surgeon, senior physician (since 2009) and associate professor (since 2011) at the ophthalmology department, University of Regensburg (Prof. Dr. H. Helbig) and attending ophthalmologist of the GVH Competence Center (Prof. E. Holler, Prof. D. Wolff, Hemato-Oncology). 2015 -2025 senior physician and associate professor at Charité – University medicine Berlin (Prof. Dr. A.M. Joussen), appointed as a full professor in 2025 to a professorship for corneal and ocular surface diseases at Charité – University Medicine Berlin.